Atlas Trials

Jiangxi Kvvit Pharmaceutical Co., Ltd.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Jiangxi Kvvit Pharmaceutical Co., Ltd.

RecordFirmDate
Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation (NCT07656376)Jiangxi Kvvit Pharmaceutical Co., Ltd.2027-06-06
Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G12D Mutation (NCT07689539)Jiangxi Kvvit Pharmaceutical Co., Ltd.2026-09-01
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KR25102 in Healthy Volunteers (NCT07618156)Jiangxi Kvvit Pharmaceutical Co., Ltd.2026-06-01
A Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of KR23248 Capsules in Healthy Adult Subjects (NCT07585383)Jiangxi Kvvit Pharmaceutical Co., Ltd.2026-05-19
Study of Single and Multiple Ascending Doses of KR23343 in Healthy Adult Participants (NCT07409922)Jiangxi Kvvit Pharmaceutical Co., Ltd.2026-02-05
Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris (NCT07345390)Jiangxi Kvvit Pharmaceutical Co., Ltd.2026-01-10
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension (NCT07113392)Jiangxi Kvvit Pharmaceutical Co., Ltd.2025-08-01

Track Jiangxi Kvvit Pharmaceutical Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.